FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to paediatrics, and may be used for increasing IL-15 expression in infant's skeletal muscles. That is ensured by introducing docosahexaenoic acid into the infant in the amount approximately 15 to 30 mg per 1 kg of infant's body weight a day and 20 to 60 mg of arachidonic acid per 1 kg of body weight. Such introduction promotes reduced IL-15 expression in infant's subcutaneous fat.
EFFECT: group of inventions provides muscle mass gain and prevents excessive fat deposition that enables avoiding obesity in an infant.
2 cl, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING OR PREVENTING SYSTEMIC INFLAMMATION | 2008 |
|
RU2468808C2 |
| FOOD COMPOSITIONS CONTAINING PUNICALAGINS | 2009 |
|
RU2542497C2 |
| BABY FOOD CONTAINING INACTIVATED POWDER | 2008 |
|
RU2468807C2 |
| METHOD OF TREATMENT, PREVENTION OR REDUCTION OF SYSTEMIC INFLAMMATORY IN CHILDREN AT ARTIFICIAL FEEDING | 2006 |
|
RU2416401C2 |
| POLYUNSATURATED FATTY ACIDS FOR TREATING DEMENTIA, AND PRE-DEMENTIA RELATED CONDITIONS | 2006 |
|
RU2444356C2 |
| METHOD FOR REDUCING THE OCCURENCE OF INFECTION IN INFANTS | 2012 |
|
RU2605198C2 |
| POWDERED BABY MILK | 2006 |
|
RU2405351C2 |
| EFFECTS OF METABOLIC IMPRINTING OF SPECIALLY DESIGNED LIPID COMPONENT | 2012 |
|
RU2586930C2 |
| ADIPOSITY RISK REDUCTION | 2010 |
|
RU2559646C2 |
| BREAST MILK OLIGOSACCHARIDES FOR HEALTH BENEFICIAL EFFECTS THROUGH PREVENTION OF EARLY FAT RICOCHET | 2017 |
|
RU2793556C2 |
